• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Hemabate (carboprost tromethamine) Sterile Solution Injection

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

December 2013

Summary View

CONTRAINDICATIONS

  • Hypersensitivity (including anaphylaxis and angioedema) to HEMABATE Sterile Solution

ADVERSE REACTIONS

Postmarketing Experience
  • Hypersensitivity reactions (e.g. Anaphylactic reaction, Anaphylactic shock, Anaphylactoid reaction, Angioedema).